Authors
Loading...
Observational analysis reveals m6A modification of ADGRA3 suppresses papillary thyroid cancer cell malignancy, indicating a therapeutic target.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: